by xio | Apr 19, 2026 | Uncategorized
Why fill-finish strategy matters more than ever Cell and gene therapies are advancing quickly, but for many developers, manufacturing is now one of the biggest barriers to scale. As commercialization becomes more important, process design is now just as crucial as...
by xio | Mar 28, 2026 | Uncategorized
As Service and Support Director at Xiogenix, I have the privilege of spending a great deal of time on the road visiting tissue banks across the country. Because of that, I get to see firsthand the incredible work being done every day in regenerative health. I see the...
by xio | Mar 14, 2026 | Uncategorized
Each year, industry leaders across biotech, pharma, and advanced manufacturing gather at Advanced Therapies Week, hosted by Phacilitate, to discuss the future of cell and gene therapy. Held in San Diego, the conference serves as one of the most influential global...
by xio | Feb 26, 2026 | Uncategorized
Tissue banking demands precision, consistency, and regulatory discipline. Every donor gift must be processed with care, yet many workflows still rely heavily on manual steps that introduce variability, increase ergonomic strain, and complicate documentation. As demand...
by xio | Feb 26, 2026 | Uncategorized
In cell and gene therapy, teams devote significant time and resources to optimizing upstream and downstream processes. Yet many programs encounter unexpected challenges during the final stage: fill and finish. This step often determines whether a batch is released on...
